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Inorganic phosphate uptake is a universal function
accomplished by transporters that are present
across the living world. In contrast, no phosphate
exporter has ever been identified in metazoans.
Here, we show that depletion of XPR1, a multipass
membrane molecule initially identified as the cell-
surface receptor for xenotropic and polytropic mu-
rine leukemia retroviruses (X- and P-MLV), induced
a decrease in phosphate export and that reintroduc-
tion of various XPR1 proteins, from fruit fly to human,
rescued this defect. Inhibition of phosphate export
was also obtained with a soluble ligand generated
from the envelope-receptor-binding domain of
X-MLV in all human cell lines tested, as well as in
diverse stem cells and epithelial cells derived from
renal proximal tubules, the main site of phosphate
homeostasis regulation. These results provide new
insights on phosphate export in metazoans and the
role of Xpr1 in this function.
INTRODUCTION
Phosphate is one of the most abundant minerals in the body.
Maintenance of constant serum phosphate by hormonal regula-
tion is critical as phosphate imbalance can lead to major disor-
ders (see, for instance, Prie´ and Friedlander, 2010). Phosphate
plays various key functions; it is a major component of mem-
branes, nucleic acids, bones, and teeth, it provides the high-
energy bonds in ATP and creatine-phosphate, and it regulates
signaling and enzymatic activities via kinase and phosphatase-
mediated processes.
The bulk of dietary phosphate is imported at the brush-border
membrane of small-intestine enterocytes by the type IIb
sodium-dependent phosphate transporter, NPT2b/SLC34A2
(Hilfiker et al., 1998), whereas phosphate in glomerular filtrates
is reabsorbed by proximal tubule epithelial cells, mainly by the
apical NPT2a/SLC34A1 phosphate transporter and to a lesser
extent by NPT2c/SLC34A3 (Murer et al., 2000). However, how
phosphate taken up at the apical site of epithelial cells exits at1866 Cell Reports 3, 1866–1873, June 27, 2013 ª2013 The Authorsthe basal site remains unknown. Two other sodium-dependent
phosphate importers have been identified: PiT1/SLC20A1 and
PiT2/SLC20A2 (Kavanaugh et al., 1994; Olah et al., 1994).
They are ubiquitously expressed (Kavanaugh and Kabat, 1996)
and described as phosphate suppliers for cell metabolism
(Collins et al., 2004) and bone mineralization (Suzuki et al.,
2010; Yoshiko et al., 2007). PiT1 and PiT2 are members of
a family of cell-surface nutrient transporters that are used as
retroviral receptors (Manel et al., 2005; Overbaugh et al.,
2001), with PiT1 as the receptor of the gibbon ape leukemia
virus (GaLV) and koala endogenous retrovirus (KoRV) (O’Hara
et al., 1990; Oliveira et al., 2006), and PiT2 as the receptor of
the amphotropic murine leukemia virus (A-MLV) (Kozak et al.,
1995; van Zeijl et al., 1994).
XPR1 is another retroviral receptor, used by xenotropic and
polytropic MLV (X-MLV and P-MLV) (Battini et al., 1999; Tailor
et al., 1999; Yang et al., 1999), two gammaretroviruses that
can infect human cells (for a review, see Kozak, 2010). XPR1,
whose function has remained elusive, is a cell-surface multipass
membrane protein that contains a 180-residue-long amino-
terminal SPX domain (named after SYG1, Pho81, and XPR1)
identified in several yeast and plant proteins that play a role at
many levels of phosphate regulation, from transport to transcrip-
tional modulation (Secco et al., 2012a, 2012b). Here, we identify
XPR1 as a phosphate exporter in metazoans, a function that
does not require the SPX domain. Furthermore, we describe a
soluble and potent inhibitor of phosphate export derived from
the X-MLV envelope glycoprotein.RESULTS
XPR1 Is Widely Expressed in Human Cells and Is Not
Modulated by Phosphate
XPR1 is the entry receptor of X-MLV, a murine gammaretrovirus
that can infect human cells. Entry requires specific binding be-
tween receptors and the amino-terminal receptor-binding
domain (RBD) of the viral envelope glycoproteins (Env) (Battini
et al., 1995; Fass et al., 1997). In the absence of reliable exofacial
antibodies (data not shown; Vaughan et al., 2012), we monitored
cell-surface expression of XPR1 with a soluble ligand derived
from X-MLV Env RBD (XRBD) (Figure 1A). XRBD binding to
human HEK293T cells was specifically abolished upon
Figure 1. Human XPR1 Expression in Established Cell Lines Is In-
dependent of Extracellular Phosphate
(A) Schematic representation of the X-MLV Env and XRBD, the soluble XPR1
ligand. The signal peptide (SP), the surface subunit (SU), and the trans-
membrane subunit (TM) are indicated. The 238 amino-terminal residues are
separated from the rest of the SU by a short proline-rich region (wavy line). SP
and RBD-encoding sequences were fused to a mouse Fc tag (mFc) in order to
obtain XRBD.
(B) Binding of XRBD, the XPR1 ligand (left panels), and Koala endogenous
retrovirus receptor binding domain (KoRBD), the PiT1 ligand, (right panels) was
assayed on HEK293T cells transfected with siRNAs directed against luciferase
Cintroduction of a small interfering RNA (siRNA) targeting human
XPR1 (siXPR1) (p value % 0.001) (Figure 1B). XPR1 was ex-
pressed in all human cell lines we tested, albeit at various levels,
and absent from human red blood cells (RBC) (Figure 1C). No
binding was detected on Chinese hamster ovary (CHO) and
NIH 3T3 cell lines (Figure 1C) due to XPR1 species polymor-
phism, known to prevent X-MLV Env-mediated binding and
infection in hamster and mouse cells (Marin et al., 1999; Van Ho-
even and Miller, 2005; Yang et al., 1999).
Given the presence of a SPX domain in XPR1 and the associ-
ation of this domain to phosphate metabolism in fungal and plant
proteins (Secco et al., 2012a, 2012b), we tested whether XPR1
varied with phosphate concentration (Figure 1D). Cell-surface
XPR1 levels remained unchanged, whereas PiT1 and PiT2 levels
increased in 0 mM phosphate (Figure 1D). Furthermore, intro-
duction of human XPR1 in CHO cells did not alter phosphate up-
take, whereas that of PiT1 or PiT2 led to significantly increased
uptake (data not shown). These data and the fact that siXPR1
did not alter phosphate uptake (Figure S1A) argued against a
role of XPR1 in phosphate import.XPR1 Mediates Phosphate Export in Vertebrates
We next monitored phosphate content in culture medium of
XPR1-depleted cells. Following a 1 hr incubation in phosphate-
free medium, XPR1 knockdown with siXPR1 resulted in signifi-
cantly lower phosphate accumulation in the medium (Figure 2A,
left panel), with no effect on PiT1 and PiT2 (Figure S1B). This
was not due to a general alteration of the export machinery
because accumulation of lactate, the main exported glycolytic
product, remained unchanged (Figure 2A, right panel).
Interestingly, we found that efflux of radiolabeled phosphate
was influenced by extracellular phosphate concentration,
reaching 38% at 10 mM phosphate as compared to 25% and
17% at 1 or 0 mM phosphate, respectively (Figure 2B). Notably,
phosphate release was markedly reduced in cells wherein
siXPR1 was introduced (Figure 2C). Efflux of bona fide phos-
phate was assessed by one-dimensional thin-layer chromatog-
raphy (Figure 2D), and a marked decrease in phosphate efflux
upon introduction of siXPR1 was also observed in HeLa and
U2OS human epithelial cell lines (Figure 2E). Again, this
decrease was specific, as efflux of radiolabeled sulfate, another
divalent anion, was not altered (Figure 2F). Altogether, these
results provide evidence that XPR1 is a phosphate exporter
in vertebrates.(siLUC), XPR1 (siXPR1), or PiT1 (siPiT1). Nonspecific staining due to the sec-
ondary Alexa-Fluor-488-conjugated anti-mouse IgG Ab (filled histograms) and
specific binding (solid line histograms) are represented. Numbers indicate
specific mean fluorescence intensities (DMFI) in one representative experi-
ment (nR 3).
(C) XPR1 cell-surface expression measured as a function of XRBD binding.
Binding was tested on various human cell types, including RBC and negative
control hamster (CHO) and mouse (NIH 3T3) established cell lines. DMFI
(±SEM), as assessed by flow cytometry, is shown for each cell type (nR 3).
(D) XPR1, PiT1, and PiT2 cell-surface expression was monitored on HEK293T
with XRBD, KoRBD, and ARBD ligands, respectively. Binding was measured
after 24 hr culture in the presence of 1 mM (upper panels), 0 mM (central
panels), or 10 mM phosphate (lower panels). Numbers represent the DMFI in
one representative experiment (nR 3). See also Figure S1.
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Figure 2. XPR1 Mediates Pi Export
(A) Phosphate (left panel) and lactate (right panel)
were quantified by colorimetric assays in HEK293T
cell culture medium after transfection with control
siLUC or siXPR1 RNA, after 1 hr in phosphate-free
medium.
(B) Efflux of [33P]phosphate from HEK293T cells
was determined after a 20 min pulse. Efflux was
assessed after 30 min in the absence or presence
of phosphate (1 or 10mM). Values ± SEM represent
the percentage of [33P]phosphate efflux as the ratio
between released cell-free radioactivity and total
cellular radioactivity.
(C) Kinetics of [33P]phosphate efflux in HEK293T
cells transfected with control siLUC or siXPR1
RNAs.
(D) Thin-layer chromatography analysis of g33ATP
(lane 1), radiolabeled phosphate input medium
(lane 2), and efflux from HEK293T cells transfected
with siLUC (lane 3) or siXPR1 RNA (lane 4). Spots
corresponding to ATP and inorganic phosphate
(Pi), as well as the direction of migration, are indi-
cated. Spot intensity was measured using the Im-
ageJ software and normalized with respect to the
number of cells. Intensity of the spot in lane 4 is
50% of the intensity of the spot in lane 3. One of
three representative experiments is shown.
(E) Efflux of radiolabeled phosphate in siLUC or
siXPR1-treated human cell lines was measured
after a 30 min incubation.
(F) Efflux of radiolabeled sulfate was measured
15 min after washing in siLUC and siXPR1-treated
HEK293T cells.
Results shown in (A)–(C), (E), and (F) represent the
means ± SEM (n = 3). Each panel is representative
of three independent experiments. See also Fig-
ure S1.The SPX Domain of XPR1 Is Dispensable for Phosphate
Efflux
We further assessed the role of XPR1 in phosphate efflux after
introducing a siRNA matching the XPR1 30 UTR. This siXPR1
specifically downmodulated expression of endogenous XPR1
while allowing expression of a transfected engineered XPR1.
Both XPR1 cell-surface expression and phosphate efflux were
decreased by the siXPR1, and both were restored after reintro-
duction of a hemagglutinin (HA)-tagged human XPR1 (Fig-
ure 3A). XPR1 complementation was specific because PAR2,
the receptor of the porcine endogenous retrovirus type A
(PERV-A) and a riboflavin transporter (Yonezawa et al., 2008),
did not restore phosphate efflux despite increased cell-surface
expression as assessed by the binding of PERV-A Env RBD
(Figure 3A). Interestingly, phosphate efflux was also restored
by XPR1 isolated from various metazoans, including phyloge-
netically distant vertebrates and invertebrates (Figures 3B and
3C). Thus, XPR1 from the zebrafish (79% amino acid identity
with human XPR1) and that from the fruit fly (54% identity) com-
plemented efficiently phosphate efflux in XPR1-depleted human
cells. Proteins harboring an SPX domain play key roles in
phosphate regulation in yeast and plants (Secco et al., 2012a,1868 Cell Reports 3, 1866–1873, June 27, 2013 ª2013 The Authors2012b). Moreover, the SPX domain of XPR1 has been shown
to interact with the b subunit of the G protein heterotrimers
(Gß) and modulate cyclic AMP levels (Vaughan et al., 2012).
To address the potential role of SPX in phosphate efflux, we per-
formed complementation assays with a human XPR1 construct
recognized by XRBD, lacking the entire SPX domain (hDSPX)
and properly expressed at the plasma membrane (Figure 3D).
The hDSPX mutant was an efficient X-MLV receptor, mediating
infection in otherwise nonpermissive cells (Table S1) and fully
restored phosphate efflux in siXPR1-transfected cells (Fig-
ure 3D). Therefore, XPR1 appeared to be directly responsible
for phosphate efflux without requiring SPX-mediated Gß protein
recruitment.
XRBD Is an Efficient Inhibitor of XPR1-Mediated
Phosphate Efflux
Interaction between retroviral Env and their cognate receptors
often leads to altered transporter activities (Kavanaugh et al.,
1994; Manel et al., 2003; Rasko et al., 1999). We found that intra-
cellular X-MLV Env expression dramatically reduced phosphate
efflux, whereas a control PERV-A Env had no impact on phos-
phate efflux (Figure 4A). In contrast, PERV-A Env efficiently
Figure 3. Rescue of Phosphate Efflux by XPR1 Overexpression Is Independent of Its SPX Domain
(A) Efflux of [33P]phosphate after transfection with the indicated combinations of siLUC or siRNA matching the XPR1 30 UTR (siXPR1) and HA-tagged receptor
expression vectors encoding human wild-type XPR1 (hXPR1) or PAR2 (hPAR2). Means ± SEM (n = 3) are shown and results are representative of three inde-
pendent experiments. Receptor expression was monitored in parallel, assessing XPR1 or PAR2 ligand binding by flow cytometry. Representative histograms
showing nonspecific (filled) and specific (solid line) staining are presented.
(B) [33P]phosphate efflux in cells transfected with siLUC (1) or siXPR1, either alone (2) or in combination with HA-tagged XPR1 expression vectors from different
species (fruit fly [3], zebrafish [4], opossum [5], cat [6], and human [7]).
(C) Immunoblot of XPR1 in cell lysates with an anti-HA antibody (3F10, Roche Applied Science) (upper panel) with b actin as loading control (lower panel).
(D) [33P]phosphate efflux in cells transfected with receptor constructs harboring either the wild-type or DSPX XPR1. Flow cytometry was performed using the
XPR1 ligand and representative histograms are shown. See also Table S1.
Results shown in (A), (B), and (D) represent the means ± SEM (n = 3). One of at least three experiments is shown.downmodulated PAR2, its cognate receptor (Figure S2). To
further assess the direct interaction between X-MLV Env and
XPR1 in phosphate efflux inhibition, we coexpressed X-MLV
Env with human or rodent XPR1, as X-MLV Env does not bind
hamster and mouse (Mus musculus) XPR1 (Figure 1C; Marin
et al., 1999; Van Hoeven and Miller, 2005; Yang et al., 1999;
Kozak, 2010). X-MLV Env inhibited phosphate efflux following
transfection with human XPR1, whereas it did not impair efflux
in cells transfected with either hamster XPR1 (Figure 4B) or
mouse XPR1 (data not shown). The fact that rodent XPR1, and
not human XPR1, can compensate for defective phosphate
efflux induced by X-MLV Env was strongly in favor of a direct
interaction between X-MLV Env and human XPR1 in phosphate
efflux inhibition.CWe further showed that intracellular expression of a soluble
XRBD module that lacked the Env remainder (Figure 1A) effi-
ciently inhibited phosphate efflux mediated by XPR1 (Figure 4C),
whereas an XRBD-binding-defective mutant (M1RBD) did not
(Figure S3).
XPR1Mediates Phosphate Efflux in Various Primary and
Stem Cells
Finally, we tested whether soluble XRBD maintained XPR1-
inhibiting properties when added in culture medium. XPR1-
binding sites on human HEK293T cells were saturated in a
concentration-dependent manner with ectopically added
XRBD (Figure 4D), whereas no significant binding was achieved
on mouse cells (Figure 4D). Specific and efficient inhibition ofell Reports 3, 1866–1873, June 27, 2013 ª2013 The Authors 1869
Figure 4. XRBD Is an Inhibitor of Phosphate Export in Primary and Stem Cells
(A) [33P]phosphate efflux in HEK293T cells transfected with expression vectors containing the X-MLV, the PERV-A full-length Env, or a control empty vector. See
also Figure S2.
(B) [33P]phosphate efflux in HEK293T cells transfected with X-MLV Env vector or the corresponding control vector (pCSI) in combination with expression vectors
containing either the hamster (haXPR1) or the human XPR1 (hXPR1) genes, or the corresponding empty pCHIX vector.
(C) [33P]phosphate efflux in HEK293T cells transfected with soluble XRBD or control PERV-A RBD vectors. See also Figure S3.
(D) Saturation binding curve of purified XRBD on human HEK293T cells (dotted line) or mouse NIH 3T3 cells (solid line). XRBD was added in 5-fold increase steps
from 5.4 3 103 mg/ml to 17 mg/ml. Saturation plateau was reached at 3.4 mg/ml of purified XRBD.
(E) [33P]phosphate efflux assay on HEK293T cells (open histograms) or NIH 3T3 cells (solid histograms) incubated in medium with increasing amounts of purified
XRBD. The following concentrations were used: 1, none; 2, 3.4 mg/ml; 3, 0.136 mg/ml; and 4, 5.43 103 mg/ml XRBD. Efflux impairment wasmaximal at 3.4 mg/ml,
the saturating concentration.
(F) Inhibition of phosphate efflux in primary cells and stem cells upon addition of 3.4 mg/ml of purified XRBD. Shown are means ± SEM (n = 3). Results are
representative of three independent experiments.
See also Figure S4.phosphate efflux could also be achieved in a dose-dependent
manner with purified XRBD added to the culture medium (Fig-
ure 4E). Phosphate efflux was inhibited by XRBD in all other
human cell lines tested (data not shown).
Because primary cells are not readily transfectable, we
tested the anti-XPR1 properties of soluble XRBD directly in
the culture medium of various primary cell types, after verifying
the presence of XPR1 at the cell surface (Figure S4). Interest-
ingly, higher levels of XPR1 at the cell surface of neuronal
stem cells (NSC) were not accompanied by increased phos-
phate efflux (Figures S4 and 4F), suggesting that cofactors
might be required for phosphate efflux. Alternatively, XPR1
may exert an additional function. The concomitant transport
of different substrates has thus been described for GLUT1,
the main glucose transporter, in the context of human red
blood cells (Montel-Hagen et al., 2008). The antagonist effect
of XRBD on phosphate efflux was readily detected on human
umbilical vein endothelial cells (HUVEC) and renal proximal
tubule epithelial cells (RPTEC), as well as on various human1870 Cell Reports 3, 1866–1873, June 27, 2013 ª2013 The Authorsstem cells, including mesenchymal (MSC), NSC, skin (SSC),
and umbilical cord CD34+ hematopoietic stem cells (Figure 4F).
The significant decreases in phosphate efflux observed in these
different cell types unveiled the highly conserved role mediated
by XPR1.
DISCUSSION
Although evidence for phosphate efflux has accumulated in
diverse tissues, factors mediating phosphate export have
remained elusive. Here, we show that inorganic phosphate
efflux in human cells is accomplished by XPR1, the X-MLV
receptor (Battini et al., 1999; Tailor et al., 1999; Yang et al.,
1999). Moreover, we were able to impair phosphate efflux by
blocking XPR1 with XRBD, its X-MLV Env-derived ligand.
Although alternative pathways for phosphate export may exist,
the severity of the inhibition observed with XRBD indicated
that, in the models tested, XPR1 is the main, if not the sole,
effector of this activity.
In agreement with our findings, two reports have separately
indicated that activation of the receptor-activated NF-kB-
ligand-receptor-activated NF-kB signaling pathway in murine
osteoclasts leads to higher levels of phosphate efflux (Ito et al.,
2007) and to XPR1 upregulation (Sharma et al., 2010). Although
a direct link between the two studies is missing, we postulate
that phosphate export driven by XPR1 is likely to play a role dur-
ing bone resorption. Also, cellular efflux is important in phos-
phate homeostasis as an obligatory step of intestinal absorption
and renal reabsorption. Thus, it has been proposed that a Na+-
dependent electroneutral anion exchanger is at least partially
responsible for phosphate exit in the proximal tubule (Barac-
Nieto et al., 2002). Our finding that XRBD ligand blocked phos-
phate export in human RPTEC indicates that XPR1 is likely to
represent the ‘‘missing player’’ in trans-epithelial phosphate
transport to bloodstream.
The lack of specific antibodies directed against exofacial de-
terminants of multipass nutrient transporters is notorious (see,
for instance, Kinet et al., 2007; Yonezawa et al., 2008). This is
also the case for XPR1 (Vaughan et al., 2012). Therefore,
siRNA-mediated downmodulation of cell-surface XPR1 could
not be easily monitored. In contrast, XRBD, our XPR1 ligand, al-
lows the simple monitoring of XPR1 surface expression in
various human cell types. XPR1 appeared ubiquitous, in agree-
ment with EST databases and previous studies (Battini et al.,
1999; Tailor et al., 1999) wherein XPR1 mRNA is found in many
tissues and as early as the 2-cell stage embryos. Moreover,
XPR1 also acts as phosphate exporter in mammals as well as
in more distant species, because phosphate efflux defect could
be efficiently restored by ectopic expression of various XPR1,
from fruit fly to human. Given the high conservation of XPR1 se-
quences (over 90% amino acid identity in mammals and 79%
and 54% in zebrafish and fruit fly, respectively), it is likely that
XPR1-mediated phosphate export is a universal feature in
metazoans.
Phosphate exporters have been recently described in plants
and yeasts. Specifically, the Arabidopsis thaliana PHO1 has
been shown to play a crucial role in root phosphate efflux (Stefa-
novic et al., 2011). On the other hand, the yeast PHO91 has been
shown to function intracellularly, delivering vacuolar hydrolyzed
polyphosphate to the cytosol (Hu¨rlimann et al., 2007). The plant
PHO1 and yeast PHO91 share 21% identity with human XPR1
and also harbor an amino-terminal SPX domain. Our finding
that SPX was dispensable for phosphate export by XPR1 sug-
gested a regulatory role rather than a role in transport activity
per se, as previously reported for the PHO87 and PHO90 yeast
proteins (Ghillebert et al., 2011; Hu¨rlimann et al., 2009). More-
over, the SPX domain of SYG1, the closest yeast homolog of
XPR1 (23% identity), with no identified function, binds Gß pro-
teins (Spain et al., 1995). XPR1 has also been shown to interact
with Gß in human cells (Vaughan et al., 2012), presumably via its
SPX domain. Whether this interaction influences phosphate
export remains to be established.
Loss of phosphate homeostasis regulation can lead to hypo-
or hyperphosphatemia, with potentially severe clinical conse-
quences (Prie´ and Friedlander, 2010). Associated genetic
alterations have been found in genes involved in renal phosphate
homeostasis regulation. However, it is believed that other genesCinvolved in genetic phosphate disorders have yet to be dis-
covered. In this regard, XPR1 represents a candidate to be
taken into account when stable phosphate homeostasis is
compromised.
EXPERIMENTAL PROCEDURES
Cell origins and culture conditions, plasmids, expression vectors, molecular
constructions, siRNA, RBD preparations, binding assays, and efflux proce-
dures are detailed in the Extended Experimental Procedures.
Cell Culture, Plasmids, Expression Vectors, and siRNA
Cell cultures included human kidney HEK293T, lung A549, colon CaCo2, cer-
vical HeLa, hepatocyte Huh-7, breast MDA:MB436, pancreas PANC-1, pros-
tate PNT2, muscle TE671, bone U2OS, and Jurkat T cells; murine embryonic
fibroblast NIH 3T3 and hamster ovary CHO established cell lines; and primary
cells comprising HUVEC, RPTEC, CD34+ hematopoietic stem cells and
mesenchymal, neuronal, and skin stem cells (kindly provided by X. Nissan
and M. Peschanski, I-Stem, Evry).
Retroviral Env-Derived Ligands and Binding Assays
The KoRV, A-MLV, X-MLV (NZB-IU-6 strain), and PERV-A RBD were C-termi-
nally fused to a mouse immunoglobulin (Ig) G1 Fc fragment and produced on
HEK293T cells. Binding assays were carried as previously described (Lavanya
et al., 2008; Manel et al., 2003) or as detailed in the Extended Experimental
Procedures.
Colorimetric and Phosphate Efflux Assays
Inorganic phosphate and lactate concentrations in the culture medium were
measured using the Malachite Green Phosphate Detection Kit (R&D Systems)
and ABX Pentra Lactic Acid Kit (ABX Diagnostic), respectively. Phosphate
efflux was measured from cell monolayers or suspension cell culture medium
as the ratio of released [33P]phosphate to total cellular [33P]phosphate. [35S]
sulfate efflux was measured in similar conditions.
Thin-Layer Chromatography
Samples (1.5 ml) were loaded on polyethylenimine-cellulose plates and run
vertically in closed chambers with 0.5–0.8 cm of solvent (KH2PO4 0.85 M
adjusted to pH 3.4 with H3PO4), as recently described for quantification of
intracellular nucleoside triphosphates (Jendresen et al., 2011). Dried plates
were exposed for [33P] radioactivity in a storage phosphor screen overnight
and scanned with a Typhoon 9200 Imager (GE Healthcare).
Statistical Analysis
Data are expressed as means ± SEM. All p values were calculated using
Student’s t test in GraphPad Prism 5 software, and the following convention
was used throughout the paper: *p % 0.05; **p % 0.01; ***p % 0.001;
****p% 0.0001.
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